KIORA PHARMACEUTICALS, INC. Share Price
KIORA PHARMACEUTICALS, INC. (KPRX) had Share Price of $2.63 per share as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2026-08-07
- 2026-06-30: Share Price $2.63.
- 2026-03-31: Share Price $1.93.
- 2025-12-31: Share Price $1.97.
- 2025-09-30: Share Price $2.78.
| Period end | Share Price | Share Price as first filed |
|---|---|---|
| 2026-06-30 | $2.63 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $1.93 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.97 10-K · filed 2026-03-25 | |
| 2025-09-30 | $2.78 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $2.88 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $3.01 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $3.30 10-K · filed 2026-03-25 | |
| 2024-09-30 | $3.66 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $4.20 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $0.71 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $4.70 10-K · filed 2025-03-25 | $0.52 10-K · filed 2024-03-25 |
| 2023-09-30 | $0.57 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $0.64 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $3.34 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $3.43 10-K · filed 2024-03-25 | |
| 2022-09-30 | $6.15 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $0.47 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $0.62 10-Q · filed 2022-07-08 | |
| 2020-12-31 | $10.00 10-K · filed 2021-03-25 | |
| 2020-01-03 | $10.00 10-K/A · filed 2022-07-07 | |
| 2018-04-17 | $4.80 10-K · filed 2021-03-25 | |
| 2017-06-14 | $22.50 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |